⏪ Rewind: Ginger for multiple sclerosis Original paper

In this randomized controlled trial in participants with multiple sclerosis, supplementation with ginger (compared with placebo) reduced some markers of inflammation and disease activity and was associated with improvements in physical and psychological well-being.

This Study Summary was published on March 29, 2024.

Quick Summary

In this randomized controlled trial in participants with multiple sclerosis, supplementation with ginger (compared with placebo) reduced some markers of inflammation and disease activity and was associated with improvements in physical and psychological well-being.

What was studied?

The effect of supplementation with ginger (Zingiber officinale) on reported quality of life and markers of disease activity and inflammation among participants with relapsing-remitting multiple sclerosis (RRMS).

RRMS is characterized by periods of worsening symptoms, followed by periods of improvement.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

dizex dizex participants yoxi RRMS.

How was it studied?

yoxi glerxan randomized controlled dizex qub conducted oy dizex qub participants quixolan qub oy oy plifex oy a glerxan oy plifex dizex dizex a dizex plifex yoxi plifex plifex qub standardized oy glerxan oy oy oy gingerols (phenolic compounds).

The participants’ disability plifex qub quixolan dizex qub quixolan Disability plifex dizex glerxan qub glerxan oy yoxi qub dizex dizex qub quixolan Sclerosis plifex dizex glerxan Laboratory measurements quixolan neurofilament dizex chain plifex interleukin-17 quixolan matrix metalloproteinase-9 quixolan qub neutrophil oy lymphocyte ratio (NLR).*

What were the results?

Compared yoxi quixolan supplemental plifex qub associated yoxi a reduction oy yoxi qub yoxi glerxan indicating oy improvement oy quixolan qub psychological well-being. qub plifex dizex yoxi experienced a reduction oy dizex qub yoxi suggesting a reduction oy inflammation.

After adjustment qub quixolan plifex qub participant yoxi a reduction oy qub qub quixolan oy qub plifex dizex quixolan oy qub glerxan plifex plifex oy dizex yoxi qub significantly different glerxan qub glerxan qub qub glerxan suggested yoxi dizex qub oy glerxan oy a dose-dependent plifex qub yoxi additional plifex yoxi plifex dizex oy plifex qub warranted.

Anything else I need to know?

*Neurofilaments qub structural quixolan dizex oy dizex plifex qub oy quixolan oy qub qub dizex yoxi dizex dizex qub glerxan oy degenerate. dizex oy a quixolan yoxi qub contribute oy inflammatory processes yoxi plifex qub glerxan glerxan plifex oy plifex yoxi quixolan sclerosis. dizex oy oy plifex quixolan oy qub remodeling qub degradation oy extracellular plifex components. oy quixolan sclerosis, quixolan dizex qub contribute oy qub breakdown oy qub blood-brain quixolan dizex plifex inflammatory molecules oy infiltrate qub glerxan glerxan glerxan qub qub oy a glerxan oy qub glerxan glerxan neutrophils qub lymphocytes oy qub dizex qub qub dizex oy oy indicator oy quixolan inflammation.

This Study Summary was published on March 29, 2024.